New Antidiabetic Therapies: A Paradigm Shift in Type 2 Diabetes Management

Curr Pharm Des. 2021;27(8):1007. doi: 10.2174/138161282708210308141311.

Authors

Theocharis Koufakis¹, Niki Katsiki¹, Kalliopi Kotsa¹

Affiliation

¹ Division of Endocrinology and Metabolism - Diabetes Center, 1st Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA, University Hospital, St. Kiriakidi Street, 54636, Thessaloniki, Greece.

PMID: 33849410
DOI: 10.2174/138161282708210308141311

No abstract available

Publication types

Editorial

MeSH terms

Diabetes Mellitus, Type 2* / drug therapy
Humans
Hypoglycemic Agents* / therapeutic use

Substances

Hypoglycemic Agents